Safety and Efficacy Study of Regulatory T Cell Therapy in Liver Transplant Patients
Status:
Completed
Trial end date:
2018-01-22
Target enrollment:
Participant gender:
Summary
'ThRIL' aims to explore the feasibility, safety and efficacy of TR002, a regulatory cell
therapy, as adjunct immunosuppressive treatment in the context of liver transplantation